Punekar, S. R., Ward, J., Park, J. C., Patel, S. P., Maloney, D. G., Dorigo, O., Kirtane, K., Maus, M. V., Morelli, M. P., Lou, Y., Block, M. S., Avila, M., Eskander, R. N., Boyd, L. R., Mardiros, A., Welch, J. S., Wise, A., Xuan, J. D., Molina, J. R., Hecht, J. R. (2025). EVEREST-2: Initial data of the logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy A2B694 for patients with solid tumors associated with mesothelin (MSLN) expression and with human leukocyte antigen (HLA) loss of heterozygosity (LOH).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3040